NCT06761443

To Evaluate the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults

Based on a Randomized, Double-blind, Placebo-controlled Trial, we Evaluated the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

To study the improvement of constipation symptoms, quality of life and mental state, intestinal function, intestinal hormones, inflammation and immunity, and intestinal flora of constipation subjects after 8-week intervention with Pediococcus acidilactici PA53.

Conditions

• Constipation

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	The experimental phase of this study had last 8 weeks and each patient will make 3 visits (week 0, week 4, week 8).
DIETARY_SUPPLEMENT	Maltodextrin	The experimental phase of this study had last 8 weeks and each patient will make 3 visits (week 0, week 4, week 8).

Timeline

• Start date: 2025-02-25
• Primary completion: 2025-04-25
• Completion: 2025-05-25
• First posted: 2025-01-07
• Last updated: 2025-01-07

Locations

1 site across 1 country: China